Skip to main content
Erschienen in: Pediatric Nephrology 11/2007

01.11.2007 | Original Article

Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project

verfasst von: Meredith A. Atkinson, Alicia M. Neu, Barbara A. Fivush, Diane L. Frankenfield

Erschienen in: Pediatric Nephrology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Ethnicity information was collected for all pediatric peritoneal dialysis patients from the End-Stage Renal Disease (ESRD) Clinical Performance Measures (CPM) Project for the period October 2004 through March 2005. Associations between intermediate outcomes and Hispanic ethnicity were determined. Thirty percent (207/696) of patients in the final cohort were Hispanic, 24% (165/696) non-Hispanic black, and 46% (324/696) non-Hispanic white. Hispanics were more likely to be female, older, and have a lower mean height standard deviation score (SDS). There were no significant differences among ethnic/racial groups regarding clearance parameters. More Hispanics had a mean hemoglobin ≥ 11 g/dl compared with non-Hispanic blacks and non-Hispanic whites (77% vs. 55% and 70%, P < 0.0001). More Hispanics compared with non-Hispanic blacks and non-Hispanic whites had a mean serum albumin ≥ 4.0/3.7 g/dl [bromcresol green/bromcresol purple laboratory method (BCG/BCP)] (50% vs. 24% and 27%, respectively, P < 0.0001). In multivariate analyses, Hispanics remained significantly more likely to achieve a mean serum albumin ≥ 4.0/3.7 g/dl (BCG/BCP) compared with non-Hispanic whites (referent) and were as likely to achieve clearance and hemoglobin targets. Pediatric Hispanic peritoneal dialysis patients experience equivalent or better intermediate outcomes of dialytic care compared with non-Hispanics. Further study is needed to understand associations of Hispanic ethnicity with outcomes such as hospitalization, transplantation, and mortality.
Literatur
1.
Zurück zum Zitat Healthy People 2010: Understanding and Improving Health (2nd edn) (2000) Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office Healthy People 2010: Understanding and Improving Health (2nd edn) (2000) Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office
2.
Zurück zum Zitat Frankenfield DL, Rocco MV, Roman SH, McClellan WM (2003) Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol 14(1):180–186PubMedCrossRef Frankenfield DL, Rocco MV, Roman SH, McClellan WM (2003) Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol 14(1):180–186PubMedCrossRef
3.
Zurück zum Zitat Frankenfield DL, Rocco MV, Frederick PR, Pugh J, McClellan WM, Owen WF Jr (1993) Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Am J Kidney Dis 34(4):721–730CrossRef Frankenfield DL, Rocco MV, Frederick PR, Pugh J, McClellan WM, Owen WF Jr (1993) Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Am J Kidney Dis 34(4):721–730CrossRef
4.
Zurück zum Zitat Pugh JA, Tuley MR, Basu S (1994) Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis 23(6):803–807PubMedCrossRef Pugh JA, Tuley MR, Basu S (1994) Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis 23(6):803–807PubMedCrossRef
5.
Zurück zum Zitat Medina RA, Pugh JA, Monterrosa A, Cornell J (1996) Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type? Am J Kidney Dis 28(2):226–234PubMedCrossRef Medina RA, Pugh JA, Monterrosa A, Cornell J (1996) Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type? Am J Kidney Dis 28(2):226–234PubMedCrossRef
6.
Zurück zum Zitat Centers for Disease Control and Prevention (1992) Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity - Colorado (1982–1989). MMWR 41(4):845–848 Centers for Disease Control and Prevention (1992) Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity - Colorado (1982–1989). MMWR 41(4):845–848
7.
Zurück zum Zitat Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ (2004) Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis 44(2):344–352PubMedCrossRef Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ (2004) Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis 44(2):344–352PubMedCrossRef
8.
Zurück zum Zitat Frankenfield DL, Atkinson MA, Fivush BA, Neu AM (2006) Outcomes for adolescent Hispanic hemodialysis patients: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis 47(5):870–878PubMedCrossRef Frankenfield DL, Atkinson MA, Fivush BA, Neu AM (2006) Outcomes for adolescent Hispanic hemodialysis patients: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis 47(5):870–878PubMedCrossRef
9.
Zurück zum Zitat Frankenfield DL, Roman SH, Rocco MV, Bedinger MR, McClellan WM (2004) Disparity in outcomes for adult Native American hemodialysis patients? Findings from the ESRD Clinical Performance Measures Project, 1996 to 1999. Kidney Int 65(4):1426–1434PubMedCrossRef Frankenfield DL, Roman SH, Rocco MV, Bedinger MR, McClellan WM (2004) Disparity in outcomes for adult Native American hemodialysis patients? Findings from the ESRD Clinical Performance Measures Project, 1996 to 1999. Kidney Int 65(4):1426–1434PubMedCrossRef
10.
Zurück zum Zitat Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21(2):138–144PubMedCrossRef Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21(2):138–144PubMedCrossRef
11.
Zurück zum Zitat Carfray A, Patel K, Whitaker P, Garrick P, Grittiths GJ, Warwick GL (2000) Albumin as an outcome measure in haemodialysis patients: the effect of variation in assay method. Nephrol Dial Transplant 15(11):1819–1822PubMedCrossRef Carfray A, Patel K, Whitaker P, Garrick P, Grittiths GJ, Warwick GL (2000) Albumin as an outcome measure in haemodialysis patients: the effect of variation in assay method. Nephrol Dial Transplant 15(11):1819–1822PubMedCrossRef
12.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1–27 Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1–27
13.
Zurück zum Zitat Ifudu O, Dawood M, Iofel Y, Valcourt JS, Friedman EA (1999) Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis 33(4):728–733PubMedCrossRef Ifudu O, Dawood M, Iofel Y, Valcourt JS, Friedman EA (1999) Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis 33(4):728–733PubMedCrossRef
14.
Zurück zum Zitat Pugh JA, Medina RA, Cornell JC, Basu S (1995) NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes 44(12):1375–1380PubMedCrossRef Pugh JA, Medina RA, Cornell JC, Basu S (1995) NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes 44(12):1375–1380PubMedCrossRef
15.
Zurück zum Zitat Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ (2000) Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol 11(12):2351–2357PubMed Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ (2000) Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol 11(12):2351–2357PubMed
16.
17.
Zurück zum Zitat Schiff M, Key CR, Gilliland FD, Becker TM (1997) Ethnic differences in uterine corpus cancer incidence and mortality in New Mexico's American Indians, Hispanics and non-Hispanic whites. Int J Epidemiol 26(2):249–255PubMedCrossRef Schiff M, Key CR, Gilliland FD, Becker TM (1997) Ethnic differences in uterine corpus cancer incidence and mortality in New Mexico's American Indians, Hispanics and non-Hispanic whites. Int J Epidemiol 26(2):249–255PubMedCrossRef
18.
Zurück zum Zitat Canto JG, Taylor HA, Jr., Rogers WJ, Sanderson B, Hilbe J, Barron HV (1998) Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol 82(9):1013–1018PubMedCrossRef Canto JG, Taylor HA, Jr., Rogers WJ, Sanderson B, Hilbe J, Barron HV (1998) Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol 82(9):1013–1018PubMedCrossRef
19.
Zurück zum Zitat Meyerowitz BE, Richardson J, Hudson S, Leedham B (1998) Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull 123(1):47–70PubMedCrossRef Meyerowitz BE, Richardson J, Hudson S, Leedham B (1998) Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull 123(1):47–70PubMedCrossRef
20.
Zurück zum Zitat Liao Y, Cooper RS, Cao G, Durazo-Arvizu R, Kaufman JS, Luke A, McGee DL (1998) Mortality patterns among adult Hispanics: findings from the NHIS, 1986–1990. Am J Public Health 88(2):227–232PubMedPubMedCentralCrossRef Liao Y, Cooper RS, Cao G, Durazo-Arvizu R, Kaufman JS, Luke A, McGee DL (1998) Mortality patterns among adult Hispanics: findings from the NHIS, 1986–1990. Am J Public Health 88(2):227–232PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Franzini L, Ribble JC, Keddie AM (2001) Understanding the Hispanic paradox. Ethn Dis 11(3):496–518PubMed Franzini L, Ribble JC, Keddie AM (2001) Understanding the Hispanic paradox. Ethn Dis 11(3):496–518PubMed
22.
Zurück zum Zitat Abraido-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner JB (1999) The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses. Am J Public Health 89(10):1543–1548PubMedPubMedCentralCrossRef Abraido-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner JB (1999) The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses. Am J Public Health 89(10):1543–1548PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Markides KS, Coreil J (1986) The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep 101(3):253–265PubMedPubMedCentral Markides KS, Coreil J (1986) The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep 101(3):253–265PubMedPubMedCentral
24.
Zurück zum Zitat Ramirez RR, de la Cruz GP (2003) The Hispanic population in the United States: March 2002. U.S. Census Bureau, Washington, D.C. Ramirez RR, de la Cruz GP (2003) The Hispanic population in the United States: March 2002. U.S. Census Bureau, Washington, D.C.
26.
Zurück zum Zitat Nzerue CM, Demissochew H, Tucker JK (2002) Race and kidney disease: role of social and environmental factors. J Natl Med Assoc 94(8 Suppl):28S–38SPubMedPubMedCentral Nzerue CM, Demissochew H, Tucker JK (2002) Race and kidney disease: role of social and environmental factors. J Natl Med Assoc 94(8 Suppl):28S–38SPubMedPubMedCentral
27.
Zurück zum Zitat Centers for Medicare & Medicaid Services (2006) 2005 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis 48(Suppl 2):S1–S106 Centers for Medicare & Medicaid Services (2006) 2005 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis 48(Suppl 2):S1–S106
28.
Zurück zum Zitat USRDS (2005) Annual Data Report: Atlas of End-Stage Renal Disease in the United Sates. U.S. Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD USRDS (2005) Annual Data Report: Atlas of End-Stage Renal Disease in the United Sates. U.S. Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
29.
Zurück zum Zitat Powe NR, Tarver-Carr ME, Eberhardt MS, Brancati FL (2003) Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Kidney Dis 42(2):249–255PubMedCrossRef Powe NR, Tarver-Carr ME, Eberhardt MS, Brancati FL (2003) Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Kidney Dis 42(2):249–255PubMedCrossRef
30.
Zurück zum Zitat Freedman DS, Khan LK, Serdula MK, Ogden CL, Dietz WH (2006) Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity 14(2):301–308PubMedCrossRef Freedman DS, Khan LK, Serdula MK, Ogden CL, Dietz WH (2006) Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity 14(2):301–308PubMedCrossRef
31.
Zurück zum Zitat Perez-Padilla R, Rojas R, Torres V, Borja-Aburto V, Olaiz G, Group TEW (2006) Obesity among children residing in Mexico City and its impact on lung function: a comparison with Mexican-Americans. Arch Med Res 37(1):165–171PubMedCrossRef Perez-Padilla R, Rojas R, Torres V, Borja-Aburto V, Olaiz G, Group TEW (2006) Obesity among children residing in Mexico City and its impact on lung function: a comparison with Mexican-Americans. Arch Med Res 37(1):165–171PubMedCrossRef
32.
Zurück zum Zitat Sorof JM, Hawkins EP, Brewer ED, Boydstun, II, Kale AS, Powell DR (1998) Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 12(9):764–768PubMedCrossRef Sorof JM, Hawkins EP, Brewer ED, Boydstun, II, Kale AS, Powell DR (1998) Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 12(9):764–768PubMedCrossRef
34.
Zurück zum Zitat Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69(10):1846–1851PubMedCrossRef Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69(10):1846–1851PubMedCrossRef
35.
Zurück zum Zitat National Kidney Foundation; Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) (2006) Clinical Practice Recommendations for Peritoneal Dialysis Adequacy; Guideline 6: Pediatric Peritoneal Dialysis National Kidney Foundation; Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) (2006) Clinical Practice Recommendations for Peritoneal Dialysis Adequacy; Guideline 6: Pediatric Peritoneal Dialysis
36.
Zurück zum Zitat Rocco MV, Frankenfield DL, Frederick PR, Pugh J, McClellan WM, Owen WF (2000) Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup. Perit Dial Int 20(3):328–335PubMed Rocco MV, Frankenfield DL, Frederick PR, Pugh J, McClellan WM, Owen WF (2000) Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup. Perit Dial Int 20(3):328–335PubMed
37.
Zurück zum Zitat Gunnell J, Yeun JY, Depner TA, Kaysen GA (1999) Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33(1):63–72PubMedCrossRef Gunnell J, Yeun JY, Depner TA, Kaysen GA (1999) Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33(1):63–72PubMedCrossRef
38.
Zurück zum Zitat Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB (2006) Can acidosis and hyperphosphatemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology 11(5):394–399PubMedCrossRef Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB (2006) Can acidosis and hyperphosphatemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology 11(5):394–399PubMedCrossRef
39.
Zurück zum Zitat Al-Hilali N, Al-Humoud H, Ninan VT, Nampoory MR, Puliyclil MA, Johny KV (2007) Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients? Med Princ Pract 16:63–67PubMedCrossRef Al-Hilali N, Al-Humoud H, Ninan VT, Nampoory MR, Puliyclil MA, Johny KV (2007) Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients? Med Princ Pract 16:63–67PubMedCrossRef
40.
Zurück zum Zitat Danielson B (1995) R-HuEPO hyporesponsiveness-who and why? Nephrol Dial Transplant 10(Suppl 2):69–73PubMedCrossRef Danielson B (1995) R-HuEPO hyporesponsiveness-who and why? Nephrol Dial Transplant 10(Suppl 2):69–73PubMedCrossRef
41.
Zurück zum Zitat National Kidney Foundation; Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) (2000) Clinical Practice Guidelines for Adults on Maintenance Dialysis: Evaluation of Protein-Energy Nutrition Status National Kidney Foundation; Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) (2000) Clinical Practice Guidelines for Adults on Maintenance Dialysis: Evaluation of Protein-Energy Nutrition Status
42.
Zurück zum Zitat Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG (2002) Prevalence of protein malnutrition in children maintained on peritoneal dialysis. Pediatr Nephrol 17(7):527–530PubMedCrossRef Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG (2002) Prevalence of protein malnutrition in children maintained on peritoneal dialysis. Pediatr Nephrol 17(7):527–530PubMedCrossRef
43.
Zurück zum Zitat Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA (2002) Self-Reported vs Administrative Race/Ethnicity Data and Study Results. Am J Public Health 92(9):1471–1472PubMedPubMedCentralCrossRef Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA (2002) Self-Reported vs Administrative Race/Ethnicity Data and Study Results. Am J Public Health 92(9):1471–1472PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Kressin NR, Chang BH, Hendricks A, Kazis LE (2003) Agreement between administrative data and patients' self-reports of race/ethnicity. Am J Public Health 93(10):1734–1739PubMedPubMedCentralCrossRef Kressin NR, Chang BH, Hendricks A, Kazis LE (2003) Agreement between administrative data and patients' self-reports of race/ethnicity. Am J Public Health 93(10):1734–1739PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Rosenberg HM, Maurer JD, Sorlie PD, Johnson NJ, MacDorman MF, Hoyert DL, Spitzler JF, Scott C (1999) Quality of death rates by race and Hispanic origin: a summary of current research. Vital Health Stat 2(128):1–13 Rosenberg HM, Maurer JD, Sorlie PD, Johnson NJ, MacDorman MF, Hoyert DL, Spitzler JF, Scott C (1999) Quality of death rates by race and Hispanic origin: a summary of current research. Vital Health Stat 2(128):1–13
46.
Metadaten
Titel
Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project
verfasst von
Meredith A. Atkinson
Alicia M. Neu
Barbara A. Fivush
Diane L. Frankenfield
Publikationsdatum
01.11.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 11/2007
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0593-0

Weitere Artikel der Ausgabe 11/2007

Pediatric Nephrology 11/2007 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.